Found 141 hits with Last Name = 'kamath' and Initial = 'av' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PAF mediated human eosinophil chemotaxis |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of C5a mediated human eosinophil chemotaxis |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4D |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of release of LTE4 in human whole blood |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of Eotaxin mediated by human eosinophil chemotaxis |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4D |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113041
![PNG](/data/jpeg/tenK5011/BindingDB_50113041.png) ((2R,5R)-5-Hydroxy-1-[4-(2-trifluoromethyl-benzylox...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2ccccc2C(F)(F)F)cc1 Show InChI InChI=1S/C20H21F3N2O6S/c21-20(22,23)17-4-2-1-3-13(17)12-31-15-6-8-16(9-7-15)32(29,30)25-11-14(26)5-10-18(25)19(27)24-28/h1-4,6-9,14,18,26,28H,5,10-12H2,(H,24,27)/t14-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113040
![PNG](/data/jpeg/tenK5011/BindingDB_50113040.png) ((2R,4R)-1-[4-(4-Fluoro-benzyloxy)-benzenesulfonyl]...)Show SMILES COC(=O)[C@@H]1CCN([C@H](C1)C(=O)NO)S(=O)(=O)c1ccc(OCc2ccc(F)cc2)cc1 Show InChI InChI=1S/C21H23FN2O7S/c1-30-21(26)15-10-11-24(19(12-15)20(25)23-27)32(28,29)18-8-6-17(7-9-18)31-13-14-2-4-16(22)5-3-14/h2-9,15,19,27H,10-13H2,1H3,(H,23,25)/t15-,19-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113028
![PNG](/data/jpeg/tenK5011/BindingDB_50113028.png) ((2R,4S)-4-Hydroxy-1-[4-(2-methyl-benzyloxy)-benzen...)Show SMILES Cc1ccccc1COc1ccc(cc1)S(=O)(=O)N1CC[C@H](O)C[C@@H]1C(=O)NO Show InChI InChI=1S/C20H24N2O6S/c1-14-4-2-3-5-15(14)13-28-17-6-8-18(9-7-17)29(26,27)22-11-10-16(23)12-19(22)20(24)21-25/h2-9,16,19,23,25H,10-13H2,1H3,(H,21,24)/t16-,19+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113048
![PNG](/data/jpeg/tenK5011/BindingDB_50113048.png) ((2R,5R)-1-(4-Benzyloxy-benzenesulfonyl)-5-hydroxy-...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2ccccc2)cc1 Show InChI InChI=1S/C19H22N2O6S/c22-15-6-11-18(19(23)20-24)21(12-15)28(25,26)17-9-7-16(8-10-17)27-13-14-4-2-1-3-5-14/h1-5,7-10,15,18,22,24H,6,11-13H2,(H,20,23)/t15-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113046
![PNG](/data/jpeg/tenK5011/BindingDB_50113046.png) ((2R,5R)-5-Hydroxy-1-[4-(2-iodo-benzyloxy)-benzenes...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2ccccc2I)cc1 Show InChI InChI=1S/C19H21IN2O6S/c20-17-4-2-1-3-13(17)12-28-15-6-8-16(9-7-15)29(26,27)22-11-14(23)5-10-18(22)19(24)21-25/h1-4,6-9,14,18,23,25H,5,10-12H2,(H,21,24)/t14-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113035
![PNG](/data/jpeg/tenK5011/BindingDB_50113035.png) ((2R,4S)-1-[4-(4-Chloro-benzyloxy)-benzenesulfonyl]...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C19H21ClN2O6S/c20-14-3-1-13(2-4-14)12-28-16-5-7-17(8-6-16)29(26,27)22-10-9-15(23)11-18(22)19(24)21-25/h1-8,15,18,23,25H,9-12H2,(H,21,24)/t15-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113044
![PNG](/data/jpeg/tenK5011/BindingDB_50113044.png) ((2R,5R)-5-Hydroxy-1-[4-(2-methyl-benzyloxy)-benzen...)Show SMILES Cc1ccccc1COc1ccc(cc1)S(=O)(=O)N1C[C@H](O)CC[C@@H]1C(=O)NO Show InChI InChI=1S/C20H24N2O6S/c1-14-4-2-3-5-15(14)13-28-17-7-9-18(10-8-17)29(26,27)22-12-16(23)6-11-19(22)20(24)21-25/h2-5,7-10,16,19,23,25H,6,11-13H2,1H3,(H,21,24)/t16-,19-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Interstitial collagenase
(Homo sapiens (Human)) | BDBM50113029
![PNG](/data/jpeg/tenK5011/BindingDB_50113029.png) ((2R,4R)-1-[4-(4-Fluoro-phenoxy)-benzenesulfonyl]-2...)Show SMILES COC(=O)[C@@H]1CCN([C@H](C1)C(=O)NO)S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1 Show InChI InChI=1S/C20H21FN2O7S/c1-29-20(25)13-10-11-23(18(12-13)19(24)22-26)31(27,28)17-8-6-16(7-9-17)30-15-4-2-14(21)3-5-15/h2-9,13,18,26H,10-12H2,1H3,(H,22,24)/t13-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against Matrix metalloproteinase-1 was determined |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113038
![PNG](/data/jpeg/tenK5011/BindingDB_50113038.png) ((2R,4S)-1-(4-Benzyloxy-benzenesulfonyl)-4-hydroxy-...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccccc2)cc1 Show InChI InChI=1S/C19H22N2O6S/c22-15-10-11-21(18(12-15)19(23)20-24)28(25,26)17-8-6-16(7-9-17)27-13-14-4-2-1-3-5-14/h1-9,15,18,22,24H,10-13H2,(H,20,23)/t15-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113045
![PNG](/data/jpeg/tenK5011/BindingDB_50113045.png) ((2R,5R)-1-[4-(2-Ethyl-benzyloxy)-benzenesulfonyl]-...)Show SMILES CCc1ccccc1COc1ccc(cc1)S(=O)(=O)N1C[C@H](O)CC[C@@H]1C(=O)NO Show InChI InChI=1S/C21H26N2O6S/c1-2-15-5-3-4-6-16(15)14-29-18-8-10-19(11-9-18)30(27,28)23-13-17(24)7-12-20(23)21(25)22-26/h3-6,8-11,17,20,24,26H,2,7,12-14H2,1H3,(H,22,25)/t17-,20-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113034
![PNG](/data/jpeg/tenK5011/BindingDB_50113034.png) ((2R,4S)-1-[4-(3-Chloro-benzyloxy)-benzenesulfonyl]...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2cccc(Cl)c2)cc1 Show InChI InChI=1S/C19H21ClN2O6S/c20-14-3-1-2-13(10-14)12-28-16-4-6-17(7-5-16)29(26,27)22-9-8-15(23)11-18(22)19(24)21-25/h1-7,10,15,18,23,25H,8-9,11-12H2,(H,21,24)/t15-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113037
![PNG](/data/jpeg/tenK5011/BindingDB_50113037.png) ((2R,5R)-5-Hydroxy-1-[4-(4-trifluoromethyl-benzylox...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2ccc(cc2)C(F)(F)F)cc1 Show InChI InChI=1S/C20H21F3N2O6S/c21-20(22,23)14-3-1-13(2-4-14)12-31-16-6-8-17(9-7-16)32(29,30)25-11-15(26)5-10-18(25)19(27)24-28/h1-4,6-9,15,18,26,28H,5,10-12H2,(H,24,27)/t15-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A
(Homo sapiens (Human)) | BDBM14361
![PNG](/data/jpeg/tenK1/BindingDB_14361.png) ((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4A |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113039
![PNG](/data/jpeg/tenK5011/BindingDB_50113039.png) ((2R,5R)-5-Hydroxy-1-[4-(2-isopropyl-benzyloxy)-ben...)Show SMILES CC(C)c1ccccc1COc1ccc(cc1)S(=O)(=O)N1C[C@H](O)CC[C@@H]1C(=O)NO Show InChI InChI=1S/C22H28N2O6S/c1-15(2)20-6-4-3-5-16(20)14-30-18-8-10-19(11-9-18)31(28,29)24-13-17(25)7-12-21(24)22(26)23-27/h3-6,8-11,15,17,21,25,27H,7,12-14H2,1-2H3,(H,23,26)/t17-,21-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113024
![PNG](/data/jpeg/tenK5011/BindingDB_50113024.png) ((2R,4S)-1-[4-(4-Fluoro-benzyloxy)-benzenesulfonyl]...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccc(F)cc2)cc1 Show InChI InChI=1S/C19H21FN2O6S/c20-14-3-1-13(2-4-14)12-28-16-5-7-17(8-6-16)29(26,27)22-10-9-15(23)11-18(22)19(24)21-25/h1-8,15,18,23,25H,9-12H2,(H,21,24)/t15-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113047
![PNG](/data/jpeg/tenK5011/BindingDB_50113047.png) ((2R,4S)-4-Hydroxy-1-[4-(2-methoxy-benzyloxy)-benze...)Show SMILES COc1ccccc1COc1ccc(cc1)S(=O)(=O)N1CC[C@H](O)C[C@@H]1C(=O)NO Show InChI InChI=1S/C20H24N2O7S/c1-28-19-5-3-2-4-14(19)13-29-16-6-8-17(9-7-16)30(26,27)22-11-10-15(23)12-18(22)20(24)21-25/h2-9,15,18,23,25H,10-13H2,1H3,(H,21,24)/t15-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113021
![PNG](/data/jpeg/tenK5011/BindingDB_50113021.png) ((2R,4S)-1-[4-(3-Cyano-benzyloxy)-benzenesulfonyl]-...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2cccc(c2)C#N)cc1 Show InChI InChI=1S/C20H21N3O6S/c21-12-14-2-1-3-15(10-14)13-29-17-4-6-18(7-5-17)30(27,28)23-9-8-16(24)11-19(23)20(25)22-26/h1-7,10,16,19,24,26H,8-9,11,13H2,(H,22,25)/t16-,19+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113033
![PNG](/data/jpeg/tenK5011/BindingDB_50113033.png) ((2R,5R)-5-Hydroxy-1-[4-(3-trifluoromethyl-benzylox...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2cccc(c2)C(F)(F)F)cc1 Show InChI InChI=1S/C20H21F3N2O6S/c21-20(22,23)14-3-1-2-13(10-14)12-31-16-5-7-17(8-6-16)32(29,30)25-11-15(26)4-9-18(25)19(27)24-28/h1-3,5-8,10,15,18,26,28H,4,9,11-12H2,(H,24,27)/t15-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113027
![PNG](/data/jpeg/tenK5011/BindingDB_50113027.png) ((2R,4S)-4-Hydroxy-1-[4-(2-trifluoromethyl-benzylox...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccccc2C(F)(F)F)cc1 Show InChI InChI=1S/C20H21F3N2O6S/c21-20(22,23)17-4-2-1-3-13(17)12-31-15-5-7-16(8-6-15)32(29,30)25-10-9-14(26)11-18(25)19(27)24-28/h1-8,14,18,26,28H,9-12H2,(H,24,27)/t14-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113025
![PNG](/data/jpeg/tenK5011/BindingDB_50113025.png) ((2R,5R)-5-Hydroxy-1-[4-(naphthalen-1-ylmethoxy)-be...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2cccc3ccccc23)cc1 Show InChI InChI=1S/C23H24N2O6S/c26-18-8-13-22(23(27)24-28)25(14-18)32(29,30)20-11-9-19(10-12-20)31-15-17-6-3-5-16-4-1-2-7-21(16)17/h1-7,9-12,18,22,26,28H,8,13-15H2,(H,24,27)/t18-,22-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113023
![PNG](/data/jpeg/tenK5011/BindingDB_50113023.png) ((2R,4S)-4-Hydroxy-1-[4-(3-methyl-benzyloxy)-benzen...)Show SMILES Cc1cccc(COc2ccc(cc2)S(=O)(=O)N2CC[C@H](O)C[C@@H]2C(=O)NO)c1 Show InChI InChI=1S/C20H24N2O6S/c1-14-3-2-4-15(11-14)13-28-17-5-7-18(8-6-17)29(26,27)22-10-9-16(23)12-19(22)20(24)21-25/h2-8,11,16,19,23,25H,9-10,12-13H2,1H3,(H,21,24)/t16-,19+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Interstitial collagenase
(Homo sapiens (Human)) | BDBM50113049
![PNG](/data/jpeg/tenK5011/BindingDB_50113049.png) ((2R,4R)-2-Hydroxycarbamoyl-1-(4-methoxy-benzenesul...)Show SMILES COC(=O)[C@@H]1CCN([C@H](C1)C(=O)NO)S(=O)(=O)c1ccc(OC)cc1 Show InChI InChI=1S/C15H20N2O7S/c1-23-11-3-5-12(6-4-11)25(21,22)17-8-7-10(15(19)24-2)9-13(17)14(18)16-20/h3-6,10,13,20H,7-9H2,1-2H3,(H,16,18)/t10-,13-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against Matrix metalloproteinase-1 was determined |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113030
![PNG](/data/jpeg/tenK5011/BindingDB_50113030.png) ((2R,4S)-4-Hydroxy-1-[4-(4-methyl-benzyloxy)-benzen...)Show SMILES Cc1ccc(COc2ccc(cc2)S(=O)(=O)N2CC[C@H](O)C[C@@H]2C(=O)NO)cc1 Show InChI InChI=1S/C20H24N2O6S/c1-14-2-4-15(5-3-14)13-28-17-6-8-18(9-7-17)29(26,27)22-11-10-16(23)12-19(22)20(24)21-25/h2-9,16,19,23,25H,10-13H2,1H3,(H,21,24)/t16-,19+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113043
![PNG](/data/jpeg/tenK5011/BindingDB_50113043.png) ((2R,4S)-1-[4-(3-Fluoro-benzyloxy)-benzenesulfonyl]...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2cccc(F)c2)cc1 Show InChI InChI=1S/C19H21FN2O6S/c20-14-3-1-2-13(10-14)12-28-16-4-6-17(7-5-16)29(26,27)22-9-8-15(23)11-18(22)19(24)21-25/h1-7,10,15,18,23,25H,8-9,11-12H2,(H,21,24)/t15-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113042
![PNG](/data/jpeg/tenK5011/BindingDB_50113042.png) ((2R,4S)-1-[4-(4-Cyano-benzyloxy)-benzenesulfonyl]-...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccc(cc2)C#N)cc1 Show InChI InChI=1S/C20H21N3O6S/c21-12-14-1-3-15(4-2-14)13-29-17-5-7-18(8-6-17)30(27,28)23-10-9-16(24)11-19(23)20(25)22-26/h1-8,16,19,24,26H,9-11,13H2,(H,22,25)/t16-,19+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113036
![PNG](/data/jpeg/tenK5011/BindingDB_50113036.png) ((2R,4S)-4-Hydroxy-1-[4-(3-methoxy-benzyloxy)-benze...)Show SMILES COc1cccc(COc2ccc(cc2)S(=O)(=O)N2CC[C@H](O)C[C@@H]2C(=O)NO)c1 Show InChI InChI=1S/C20H24N2O7S/c1-28-17-4-2-3-14(11-17)13-29-16-5-7-18(8-6-16)30(26,27)22-10-9-15(23)12-19(22)20(24)21-25/h2-8,11,15,19,23,25H,9-10,12-13H2,1H3,(H,21,24)/t15-,19+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM14361
![PNG](/data/jpeg/tenK1/BindingDB_14361.png) ((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4D |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM14361
![PNG](/data/jpeg/tenK1/BindingDB_14361.png) ((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4B |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113022
![PNG](/data/jpeg/tenK5011/BindingDB_50113022.png) ((2R,4S)-1-[4-(2-Chloro-benzyloxy)-benzenesulfonyl]...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccccc2Cl)cc1 Show InChI InChI=1S/C19H21ClN2O6S/c20-17-4-2-1-3-13(17)12-28-15-5-7-16(8-6-15)29(26,27)22-10-9-14(23)11-18(22)19(24)21-25/h1-8,14,18,23,25H,9-12H2,(H,21,24)/t14-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113031
![PNG](/data/jpeg/tenK5011/BindingDB_50113031.png) ((2R,5R)-1-[4-(2-Cyano-benzyloxy)-benzenesulfonyl]-...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2ccccc2C#N)cc1 Show InChI InChI=1S/C20H21N3O6S/c21-11-14-3-1-2-4-15(14)13-29-17-6-8-18(9-7-17)30(27,28)23-12-16(24)5-10-19(23)20(25)22-26/h1-4,6-9,16,19,24,26H,5,10,12-13H2,(H,22,25)/t16-,19-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50176521
![PNG](/data/jpeg/tenK5017/BindingDB_50176521.png) (5-methyl-6-oxo-6,7-dihydro-5H-furo[2,3-f]indole-7-...)Show InChI InChI=1S/C14H10N4O3S/c1-18-9-4-7-2-3-21-10(7)5-8(9)11(13(18)20)12(19)16-14-17-15-6-22-14/h2-6,11H,1H3,(H,16,17,19) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against PDE2 by scintillation proximity assay |
Bioorg Med Chem Lett 16: 307-10 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.005 BindingDB Entry DOI: 10.7270/Q2XD118H |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM14361
![PNG](/data/jpeg/tenK1/BindingDB_14361.png) ((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of release of LTE4 in human whole blood |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM14361
![PNG](/data/jpeg/tenK1/BindingDB_14361.png) ((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of release of LTE4 in human whole blood |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113026
![PNG](/data/jpeg/tenK5011/BindingDB_50113026.png) ((2R,5R)-1-[4-(3-Cyano-benzyloxy)-benzenesulfonyl]-...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2cccc(c2)C#N)cc1 Show InChI InChI=1S/C20H21N3O6S/c21-11-14-2-1-3-15(10-14)13-29-17-5-7-18(8-6-17)30(27,28)23-12-16(24)4-9-19(23)20(25)22-26/h1-3,5-8,10,16,19,24,26H,4,9,12-13H2,(H,22,25)/t16-,19-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113020
![PNG](/data/jpeg/tenK5011/BindingDB_50113020.png) ((2R,4S)-1-[4-(Biphenyl-2-ylmethoxy)-benzenesulfony...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccccc2-c2ccccc2)cc1 Show InChI InChI=1S/C25H26N2O6S/c28-20-14-15-27(24(16-20)25(29)26-30)34(31,32)22-12-10-21(11-13-22)33-17-19-8-4-5-9-23(19)18-6-2-1-3-7-18/h1-13,20,24,28,30H,14-17H2,(H,26,29)/t20-,24+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113032
![PNG](/data/jpeg/tenK5011/BindingDB_50113032.png) ((2R,4S)-1-[4-(2-Fluoro-benzyloxy)-benzenesulfonyl]...)Show SMILES ONC(=O)[C@H]1C[C@@H](O)CCN1S(=O)(=O)c1ccc(OCc2ccccc2F)cc1 Show InChI InChI=1S/C19H21FN2O6S/c20-17-4-2-1-3-13(17)12-28-15-5-7-16(8-6-15)29(26,27)22-10-9-14(23)11-18(22)19(24)21-25/h1-8,14,18,23,25H,9-12H2,(H,21,24)/t14-,18+/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4A |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113029
![PNG](/data/jpeg/tenK5011/BindingDB_50113029.png) ((2R,4R)-1-[4-(4-Fluoro-phenoxy)-benzenesulfonyl]-2...)Show SMILES COC(=O)[C@@H]1CCN([C@H](C1)C(=O)NO)S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1 Show InChI InChI=1S/C20H21FN2O7S/c1-29-20(25)13-10-11-23(18(12-13)19(24)22-26)31(27,28)17-8-6-16(7-9-17)30-15-4-2-14(21)3-5-15/h2-9,13,18,26H,10-12H2,1H3,(H,22,24)/t13-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant tumor necrosis factor alpha converting enzyme |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 185 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4B |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM14361
![PNG](/data/jpeg/tenK1/BindingDB_14361.png) ((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 625 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of release of TNF alpha in human whole blood |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM28393
![PNG](/data/jpeg/tenK2/BindingDB_28393.png) ((+)-EHNA | (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-...)Show InChI InChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| Purchase
CHEMBL DrugBank MMDB PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 635 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against PDE2 by scintillation proximity assay |
Bioorg Med Chem Lett 16: 307-10 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.005 BindingDB Entry DOI: 10.7270/Q2XD118H |
More data for this Ligand-Target Pair | ![3D 3D](/images/Docked_3d.png) 3D Structure (crystal) |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(Homo sapiens (Human)) | BDBM50176377
![PNG](/data/jpeg/tenK5017/BindingDB_50176377.png) ((R)-2-(4-fluorophenoxy)-N-(1-(thiophen-2-yl)ethyl)...)Show InChI InChI=1S/C18H15FN2O2S/c1-12(16-5-3-11-24-16)21-17(22)15-4-2-10-20-18(15)23-14-8-6-13(19)7-9-14/h2-12H,1H3,(H,21,22)/t12-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 925 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer, Inc.
Curated by ChEMBL
| Assay Description Inhibition of release of TNF alpha in human whole blood |
Bioorg Med Chem Lett 16: 718-21 (2005)
Article DOI: 10.1016/j.bmcl.2005.10.026 BindingDB Entry DOI: 10.7270/Q2348JXP |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113045
![PNG](/data/jpeg/tenK5011/BindingDB_50113045.png) ((2R,5R)-1-[4-(2-Ethyl-benzyloxy)-benzenesulfonyl]-...)Show SMILES CCc1ccccc1COc1ccc(cc1)S(=O)(=O)N1C[C@H](O)CC[C@@H]1C(=O)NO Show InChI InChI=1S/C21H26N2O6S/c1-2-15-5-3-4-6-16(15)14-29-18-8-10-19(11-9-18)30(27,28)23-13-17(24)7-12-20(23)21(25)22-26/h3-6,8-11,17,20,24,26H,2,7,12-14H2,1H3,(H,22,25)/t17-,20-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibition of TNF-alpha release was determined in LPS-stimulated human whole blood assay |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |
Disintegrin and metalloproteinase domain-containing protein 17
(Homo sapiens (Human)) | BDBM50113046
![PNG](/data/jpeg/tenK5011/BindingDB_50113046.png) ((2R,5R)-5-Hydroxy-1-[4-(2-iodo-benzyloxy)-benzenes...)Show SMILES ONC(=O)[C@H]1CC[C@@H](O)CN1S(=O)(=O)c1ccc(OCc2ccccc2I)cc1 Show InChI InChI=1S/C19H21IN2O6S/c20-17-4-2-1-3-13(17)12-28-15-6-8-16(9-7-15)29(26,27)22-11-14(23)5-10-18(22)19(24)21-25/h1-4,6-9,14,18,23,25H,5,10-12H2,(H,21,24)/t14-,18-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Inhibition of TNF-alpha release was determined in LPS-stimulated human whole blood assay |
Bioorg Med Chem Lett 12: 1387-90 (2002)
BindingDB Entry DOI: 10.7270/Q2GQ6X30 |
More data for this Ligand-Target Pair | |